Institute for Wealth Management LLC. lifted its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 112.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 13,563 shares of the company’s stock after acquiring an additional 7,187 shares during the quarter. Institute for Wealth Management LLC.’s holdings in HealthEquity were worth $1,285,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in HQY. Nisa Investment Advisors LLC raised its position in HealthEquity by 2.9% in the second quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock valued at $397,000 after purchasing an additional 108 shares during the period. Advisors Asset Management Inc. grew its stake in shares of HealthEquity by 4.7% in the second quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after buying an additional 110 shares in the last quarter. Ieq Capital LLC raised its holdings in shares of HealthEquity by 4.4% in the 1st quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock valued at $260,000 after buying an additional 123 shares during the period. Coldstream Capital Management Inc. raised its holdings in shares of HealthEquity by 7.3% in the 2nd quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock valued at $212,000 after buying an additional 138 shares during the period. Finally, Farther Finance Advisors LLC lifted its stake in HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after acquiring an additional 146 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.
HealthEquity Trading Down 0.7%
NASDAQ HQY opened at $92.78 on Tuesday. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The firm has a 50 day moving average of $97.27 and a two-hundred day moving average of $95.66. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $7.93 billion, a PE ratio of 42.56, a price-to-earnings-growth ratio of 1.35 and a beta of 0.18.
Analysts Set New Price Targets
Several research firms have weighed in on HQY. JMP Securities set a $122.00 target price on HealthEquity in a research report on Thursday, December 4th. Royal Bank Of Canada lifted their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. Jefferies Financial Group upped their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 price target on shares of HealthEquity in a research report on Friday, December 5th. Finally, Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $120.27.
Get Our Latest Report on HealthEquity
Insiders Place Their Bets
In other news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 17,240 shares of company stock valued at $1,640,164 in the last ninety days. Insiders own 1.50% of the company’s stock.
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Stories
- Five stocks we like better than HealthEquity
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- Trade this between 9:30 and 10:45 am EST
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
